Degos's Syndrome.

P. Hall‐Smith

DOI: https://doi.org/10.1136/bmj.1.5590.512-b

1968-02-24

British Medical Journal

Abstract:

What problem does this paper attempt to address?

Enabling responsible public genomics

John M Conley,Adam K Doerr,Daniel B Vorhaus

Abstract:As scientific understandings of genetics advance, researchers require increasingly rich datasets that combine genomic data from large numbers of individuals with medical and other personal information. Linking individuals' genetic data and personal information precludes anonymity and produces medically significant information--a result not contemplated by the established legal and ethical conventions governing human genomic research. To pursue the next generation of human genomic research and commerce in a responsible fashion, scientists, lawyers, and regulators must address substantial new issues, including researchers' duties with respect to clinically significant data, the challenges to privacy presented by genomic data, the boundary between genomic research and commerce, and the practice of medicine. This Article presents a new model for understanding and addressing these new challenges--a "public genomics" premised on the idea that ethically, legally, and socially responsible genomics research requires openness, not privacy, as its organizing principle. Responsible public genomics combines the data contributed by informed and fully consenting information altruists and the research potential of rich datasets in a genomic commons that is freely and globally available. This Article examines the risks and benefits of this public genomics model in the context of an ambitious genetic research project currently under way--the Personal Genome Project. This Article also (i) demonstrates that large-scale genomic projects are desirable, (ii) evaluates the risks and challenges presented by public genomics research, and (iii) determines that the current legal and regulatory regimes restrict beneficial and responsible scientific inquiry while failing to adequately protect participants. The Article concludes by proposing a modified normative and legal framework that embraces and enables a future of responsible public genomics.
Public perceptions of international genetic information sharing for biomedical research in China: a case study of the social media debate on the article "A Pangenome Reference of 36 Chinese Populations" published in Nature

Zhangyu Wang,Meng Wang,Li Du

DOI: https://doi.org/10.1186/s40246-024-00650-4

2024-08-07

Abstract:Background: The international disclosure of Chinese human genetic data continues to be a contentious issue in China, generating public debates in both traditional and social media channels. Concerns have intensified after Chinese scientists' research on pangenome data was published in the prestigious journal Nature. Methods: This study scrutinized microblogs posted on Weibo, a popular Chinese social media site, in the two months immediately following the publication (June 14, 2023-August 21, 2023). Content analysis was conducted to assess the nature of public responses, justifications for positive or negative attitudes, and the users' overall knowledge of how Chinese human genetic information is regulated and managed in China. Results: Weibo users displayed contrasting attitudes towards the article's public disclose of pangenome research data, with 18% positive, 64% negative, and 18% neutral. Positive attitudes came primarily from verified government and media accounts, which praised the publication. In contrast, negative attitudes originated from individual users who were concerned about national security and health risks and often believed that the researchers have betrayed China. The benefits of data sharing highlighted in the commentaries included advancements in disease research and scientific progress. Approximately 16% of the microblogs indicated that Weibo users had misunderstood existing regulations and laws governing data sharing and stewardship. Conclusions: Based on the predominantly negative public attitudes toward scientific data sharing established by our study, we recommend enhanced outreach by scientists and scientific institutions to increase the public understanding of developments in genetic research, international data sharing, and associated regulations. Additionally, governmental agencies can alleviate public fears and concerns by being more transparent about their security reviews of international collaborative research involving Chinese human genetic data and its cross-border transfer.
Regulatory Barriers to US-China Collaboration for Generative AI Development in Genomic Research

Zhangyu Wang,Benjamin Gregg,Li Du

DOI: https://doi.org/10.1016/j.xgen.2024.100564

2024-01-01

Cell Genomics

Abstract:Here, we examine the challenges posed by laws in the United States and China for generative-AI-assisted genomic research collaboration. We recommend renewing the Agreement on Cooperation in Science and Technology to promote responsible principles for sharing human genomic data and to enhance transparency in research.
Ethical challenges related to biomedical data sharing in China: A systematic literature review

xiaojie li,Yali Cong

DOI: https://doi.org/10.21203/rs.3.rs-36427/v1

2020-01-01

Abstract:Abstract Background : With the advancement of information and communication technology, sharing biomedical data across organizations has become more feasible. However, a large part of China’s biomedical details still “silent” or “isolated”. Methods: To identify what ethical challenges are considered hinder biomedical data sharing, we performed a systematic literature review pertaining to biomedical data sharing in China. A total of 1919 publications were initially identified, 56 of which were included in the final synthesis after full-text screening. We used the International Ethical Guidelines for Health-related Research Involving humans (CIMOS) to identify the related ethical principles and norms. Results: We observed an abundance of ethical challenges based upon the following five overarching themes: capacity building; equitable distribution of benefits and burdens; scientific and social values; the data subjects’ rights; public trust and engagement. Conclusion :Based on these analyses, we find current sharing practice need to balance the protection of privacy and confidentiality with the promotion of data sharing. We believe privacy concerns can be attenuated by different stakeholders’ responsible participation within a principled proportionate governance model.
South Korea: in the midst of a privacy reform centered on data sharing

Hannah Kim,So Yoon Kim,Yann Joly

DOI: https://doi.org/10.1007/s00439-018-1920-1

Abstract:With rapid developments in genomic and digital technologies, genomic data sharing has become a key issue for the achievement of precision medicine in South Korea. The legal and administrative framework for data sharing and protection in this country is currently under intense scrutiny from national and international stakeholders. Policymakers are assessing the relevance of specific restrictions in national laws and guidelines for better alignment with international approaches. This manuscript will consider key issues in international genome data sharing in South Korea, including consent, privacy, security measures, compatible adequacy and oversight, and map out an approach to genomic data sharing that recognizes the importance of patient engagement and responsible use of data in South Korea.
Teaming Up? China, India and Brazil and the Issue of Benefit-Sharing from Genetic Resource Use

Valbona Muzaka,Omar Ramon Serrano

DOI: https://doi.org/10.1080/13563467.2019.1584169

IF: 3.625

2019-03-01

New Political Economy

Abstract:This article focuses on an area that has not been systematically addressed but is of crucial importance to China, India and Brazil: the global governance of genetic resources. All three are biodiversity-rich and, ever since biotechnology promised to turn DNA into gold, have been significant players in the genetic-resources regime complex. Shortcomings notwithstanding, the establishment of a new access and benefit-sharing regime constitutes a rare instance where emerging countries have succeeded in becoming rule-makers of sorts. We analyse how these three countries have sought to pursue their interests in this area, especially after the extension of national sovereignty over previously 'free' genetic resources and the erection of a complex set of rules attempting to regulate access to and benefits from their utilisation from the early 1990s onwards. Despite presenting a generally unified front in international fora, their domestic implementation differs significantly and raises questions about the continuation of a common international position. The article adds to our understanding of emerging countries' engagement with global governance by focusing on the concrete drivers and domestic processes that have motivated and shaped the agency of China, India and Brazil in this new policy regime.

economics,international relations,political science
Ethical, Legal, and Social Implications of Genomics in China: A Scoping Review and Implications for Precision Public Health.

Zhuo Chen,Wei Jiang,Jianhong Xu,Lan Jiang,Guoyu Wang

DOI: https://doi.org/10.46234/ccdcw2022.147

2022-01-01

China CDC Weekly

Abstract:We conducted a scoping review of Chinese language studies on the ethical, legal, and social implications of genomics and identified four broad themes: ethical considerations, regulatory framework, perceptions of genomics and precision medicine, and future directions of genomics. Ethical, legal, and social implications of genomics are growing in importance and are highly relevant to public health in China.
Collaborative analysis of genomic data: vision and challenges

Sara Jafarbeiki,Raj Gaire,Amin Sakzad,Shabnam Kasra Kermanshahi,Ron Steinfeld

DOI: https://doi.org/10.48550/arXiv.2202.04841

2022-02-10

Cryptography and Security

Abstract:The cost of DNA sequencing has resulted in a surge of genetic data being utilised to improve scientific research, clinical procedures, and healthcare delivery in recent years. Since the human genome can uniquely identify an individual, this characteristic also raises security and privacy concerns. In order to balance the risks and benefits, governance mechanisms including regulatory and ethical controls have been established, which are prone to human errors and create hindrance for collaboration. Over the past decade, technological methods are also catching up that can support critical discoveries responsibly. In this paper, we explore regulations and ethical guidelines and propose our visions of secure/private genomic data storage/processing/sharing platforms. Then, we present some available techniques and a conceptual system model that can support our visions. Finally, we highlight the open issues that need further investigation.
Resistance training during unweighting maintains muscle size and function in human calf.

H. Akima,Junichi Ushiyama,J. Kubo,Shinpei Tonosaki,M. Itoh,Y. Kawakami,H. Fukuoka,H. Kanehisa,T. Fukunaga

DOI: https://doi.org/10.1249/01.MSS.0000058367.66796.35

2003-04-01

Medicine & Science in Sports & Exercise

Abstract:PURPOSE A 20-d 6 degrees head-down tilt bed rest project was conducted to evaluate the effect of dynamic leg press and plantar flexion resistance training on muscle size and function in human plantar flexors (PF) throughout the prolonged bed rest. METHODS Twelve healthy men participated in this study and were divided two groups: resistance training (BR-Tr group: N = 6, age: 23 +/- 2 yr, height: 170 +/- 3 cm, weight: 66 +/- 7 kg) and nontraining (BR-Cont group: N = 6, age: 23 +/- 1 yr, height: 170 +/- 3 cm, weight: 67 +/- 6 kg) during the bed rest. Physiological cross-sectional area (PCSA) and peak torque of the PF muscle group was determined. Spin-spin relaxation times (T2) of the medial (MG) and lateral gastrocnemius (LG) and soleus (Sol) muscle was measured at rest and immediately after unilateral calf-raising exercise (5 sets of 10 reps). RESULTS PCSA of the PF muscle group did not show any significant change in BR-Tr group; however, for the BR-Cont group, PCSA decreased by 13% after bed rest (P < 0.05). There was no significant change in exercise-induced T2 change of the MG, LG, or Sol muscles between before and after the bed rest in BR-Tr group; however, in the BR-Cont group, significant increases in T2 were found in these three muscles after the bed rest (P < 0.05 to 0.01). CONCLUSION We conclude that dynamic leg press and plantar flexion resistance training during bed rest maintains muscle size and function (torque and T2), and that this training could be useful for prevention of progressive muscle deconditioning during spaceflight.
The ethics weathervane

Bartha Maria Knoppers,Ruth Chadwick

DOI: https://doi.org/10.1186/s12910-015-0054-4

2015-09-04

Abstract:Background: Global collaboration in genomic research is increasingly both a scientific reality and an ethical imperative. This past decade has witnessed the emergence of six new, interconnected areas of ethical consensus and emphasis for policy in genomics: governance, security, empowerment, transparency, the right not to know, and globalization. Discussion: The globalization of genomic research warrants an approach to governance policies grounded in human rights. A human rights approach activates the ethical principles underpinning genomic research. It lends force to the right of all citizens to benefit from scientific progress, and to the right of all scientists to be recognized for their contributions.
Privacy in the Genomic Era

Muhammad Naveed,Erman Ayday,Ellen W. Clayton,Jacques Fellay,Carl A. Gunter,Jean-Pierre Hubaux,Bradley A. Malin,XiaoFeng Wang

DOI: https://doi.org/10.48550/arXiv.1405.1891

2015-06-17

Abstract:Genome sequencing technology has advanced at a rapid pace and it is now possible to generate highly-detailed genotypes inexpensively. The collection and analysis of such data has the potential to support various applications, including personalized medical services. While the benefits of the genomics revolution are trumpeted by the biomedical community, the increased availability of such data has major implications for personal privacy; notably because the genome has certain essential features, which include (but are not limited to) (i) an association with traits and certain diseases, (ii) identification capability (e.g., forensics), and (iii) revelation of family relationships. Moreover, direct-to-consumer DNA testing increases the likelihood that genome data will be made available in less regulated environments, such as the Internet and for-profit companies. The problem of genome data privacy thus resides at the crossroads of computer science, medicine, and public policy. While the computer scientists have addressed data privacy for various data types, there has been less attention dedicated to genomic data. Thus, the goal of this paper is to provide a systematization of knowledge for the computer science community. In doing so, we address some of the (sometimes erroneous) beliefs of this field and we report on a survey we conducted about genome data privacy with biomedical specialists. Then, after characterizing the genome privacy problem, we review the state-of-the-art regarding privacy attacks on genomic data and strategies for mitigating such attacks, as well as contextualizing these attacks from the perspective of medicine and public policy. This paper concludes with an enumeration of the challenges for genome data privacy and presents a framework to systematize the analysis of threats and the design of countermeasures as the field moves forward.

Cryptography and Security
Effect of Side Feed Pressurization on the Performance of Shimmed Foil Gas Bearings-Part II : Model , Predictions and Comparisons to Rotordynamic Measurements

Tae Ho Kim,L. Andrés

Abstract:Oil-free micro turbomachinery implementing gas foil bearings (GFBs) has improved mechanical efficiency and reliability. Adequate thermal management for operation in high temperature environments is an issue of importance in applications such as in gas turbines and turbochargers. GFBs often need a cooling gas flow, axially fed through one end of the bearings, to transport the heat conducted from a hot turbine, for example. Side gas pressurization has also a paramount effect on reducing amplitudes of motion, synchronous and subsynchronous. In a comparison 2007 TRC report, shaft motion measurements in a test rotor supported on GFBs show this remarkable effect. A computational gas film model implementing the evolution of gas circumferential velocity as a function of the imposed side pressure is advanced. For tested GFBs, predicted direct stiffnesses and damping coefficients increase as the magnitude of feed pressure raises, while the difference in cross-coupled stiffnesses, directly related to rotor-bearing system stability, decreases. Predictions of threshold speed of instability and whirl frequency ratio are in close agreement with laboratory measurements. A model for GFBs with shims is introduced. The shimmed GFB, whose film clearance resembles a three lobe bearing, generates significantly larger hydrodynamic pressures than those in a conventional GFB. Shimmed GFBs operate with a smaller journal eccentricity and attitude angle than conventional GFB, and with increased direct stiffness and damping coefficients. A linear finite element rotordynamic analysis (XLTRC 2) models the test rotor supported on GFBs and predicts the system rotordynamic stability and synchronous rotor responses, phase angle and amplitude. Predicted synchronous responses are in very good agreement with the test measurements, in particular for small to moderate imbalances. As a final observation, although external pressurization aids to improve GFB rotordynamic performance; a too large supplied gas flow rate for cooling an actual high temperature application may penalize sensibly the efficiency and performance of the turbomachinery.
A nation's genes for a cure to cancer: evolving ethical, social and legal issues regarding population genetic databases

Alice Hsieh

Abstract:The advent of the human genome sequence has focused research on understanding underlying genetic links to complex diseases such as cancer, asthma and heart disease. In the past few years, individual countries, such as Iceland, Estonia, Singapore and the United Kingdom, have created national databases of their citizens' DNA for comparative research. Most recently, an international consortium including Nigeria, Japan, China and the United States launched a $100 million project called the International HapMap to map the human genome according to haplotypes, blocks of DNA that contain genetic variation. Such population genetic databases present challenging ethical, social and legal issues, yet regulation of genetic information has developed sporadically, from region to region, without a consistent international standard. Without a clear understanding of the consequences of genetic research in terms of individual and community-wide discrimination and stigmatization, genetic databases raise concerns about the protection of genetic information. This Note provides a survey of the evolving landscape of population genetic databases as a legislative and public policy tool for national and international regulators. It compares different approaches to regulating the collection and use of population genetic databases in order to understand what areas of consensus are formulating a foundation for an international standard. As the first population genetics project that will span multiple countries for the collection of DNA, the International HapMap has the potential to become an influential standard for the protection of population genetic information. This Note highlights issues among the national databases and the HapMap project that raise ethical, social and legal concerns for the future and recommends further protections for both individual donors and community interests.
Bridging the European Data Sharing Divide in Genomic Science

Fruzsina Molnár-Gábor,Michael J S Beauvais,Alexander Bernier,Maria Pilar Nicolas Jimenez,Mikel Recuero,Bartha Maria Knoppers

DOI: https://doi.org/10.2196/37236

2022-10-19

Abstract:In this viewpoint, we argue for the importance of creating data spaces for genomic research that are detached from contexts in which fundamental rights concerns related to surveillance measures override a purpose-specific balancing of fundamental rights. Genomic research relies on molecular and phenotypic data, on comparing findings within large data sets, on searchable metadata, and on translating research results into a clinical setting. These methods require sensitive genetic and health data to be shared across borders. International data sharing between the European Union (EU) or the European Economic Area and third countries has accordingly become a cornerstone of genomics. The EU General Data Protection Regulation contains rules that accord privileged status to data processing for research purposes to ensure that strict data protection requirements do not impede biomedical research. However, the General Data Protection Regulation rules applicable to international transfers of data accord no such preferential treatment to international data transfers made in the research context. The rules that govern the international transfer of data create considerable barriers to international data sharing because of the cost-intensive procedural and substantive compliance burdens that they impose. For certain jurisdictions and select use cases, there exist practically no lawful mechanisms to enable the international transfer of data because of concerns about the protection of fundamental rights. The proposed solutions further fail to address the need to share large data sets of local and regional cohorts across national borders to enable joint analyses. The European Health Data Space is an emerging federated, EU-wide data infrastructure that is intended to function as an infrastructure bringing together EU health data to improve patient care and enable the secondary use of health-related data for research purposes. Such infrastructure is implementing new institutions to support its functioning and is being implemented in reliance on a new enabling law, the regulation on the European Health Data Space. This innovation provides the opportunity to facilitate EU contribution to international genomic research efforts. The draft regulation for this data space provides for a concept of data infrastructure intended to enable cross-border data exchange and access, including access to genetic and health data for scientific analysis purposes. The draft regulation also provides for obligations of national actors aimed at making data widely available. This effort is laudable. However, in the absence of further, more fundamental changes to the manner in which the EU regulates the secondary use of health data, it is reasonable to believe that EU participation in international genomic research efforts will remain impeded.
A call to action to scale up research and clinical genomic data sharing

Zornitza Stark,David Glazer,Oliver Hofmann,Augusto Rendon,Christian R. Marshall,Geoffrey S. Ginsburg,Chris Lunt,Naomi Allen,Mark Effingham,Jillian Hastings Ward,Sue L. Hill,Raghib Ali,Peter Goodhand,Angela Page,Heidi L. Rehm,Kathryn N. North,Richard H. Scott

DOI: https://doi.org/10.1038/s41576-024-00776-0

IF: 59.581

2024-10-08

Nature Reviews Genetics

Abstract:Genomic data from millions of individuals have been generated worldwide to drive discovery and clinical impact in precision medicine. Lowering the barriers to using these data collectively is needed to equitably realize the benefits of the diversity and scale of population data. We examine the current landscape of global genomic data sharing, including the evolution of data sharing models from data aggregation through to data visiting, and for certain use cases, cross-cohort analysis using federated approaches across multiple environments. We highlight emerging examples of best practice relating to participant, patient and community engagement; evolution of technical standards, tools and infrastructure; and impact of research and health-care policy. We outline 12 actions we can all take together to scale up efforts to enable safe global data sharing and move beyond projects demonstrating feasibility to routinely cross-analysing research and clinical data sets, optimizing benefit.

genetics & heredity
Toward unrestricted use of public genomic data

Shakuntala Baichoo,Peer Bork,Mark Borodovsky,Cath Brooksbank,Antoine Danchin,Victor de Lorenzo,Philip Hugenholtz,Hans-Peter Klenk,Rob Knight,Folker Meyer,Mircea Podar,Jacques Ravel,Alejandro Reyes Muñoz,Ramon Rosselló-Móra,Susanna-Assunta Sansone,Rotem Sorek,Adrian Turjanski,Owen White,Ioannis Xenarios,Rudolf I. Amann,Benjamin J. Blencowe,Patrick S. G. Chain,Rita R. Colwell,Daniele G. Daffonchio,Pieter C. Dorrestein,Robert D. Finn,Claire M. Fraser,Jack A. Gilbert,Steven J. Hallam,John P. A. Ioannidis,Janet K. Jansson,Jihyun F. Kim,Martin G. Klotz,Konstantinos T. Konstantinidis,Nikos C. Kyrpides,Christopher E. Mason,Alice C. McHardy,Christos A. Ouzounis,Aristides A. N. Patrinos,Katherine S. Pollard,Richard J. Roberts,Patrick D. Schloss,Lynn M. Schriml,João C. Setubal,Rick L. Stevens,James M. Tiedje,Gene W. Tyson,David W. Ussery,George M. Weinstock,William B. Whitman

DOI: https://doi.org/10.1126/science.aaw1280

IF: 56.9

2019-01-25

Science

Abstract:Publication interests should not limit access to public data

multidisciplinary sciences
Future-proofing genomic data and consent management: a comprehensive review of technology innovations

Adrien Oliva,Anubhav Kaphle,Roc Reguant,Letitia M F Sng,Natalie A Twine,Yuwan Malakar,Anuradha Wickramarachchi,Marcel Keller,Thilina Ranbaduge,Eva K F Chan,James Breen,Sam Buckberry,Boris Guennewig,Matilda Haas,Alex Brown,Mark J Cowley,Natalie Thorne,Yatish Jain,Denis C Bauer

DOI: https://doi.org/10.1093/gigascience/giae021

IF: 7.658

2024-06-06

GigaScience

Abstract:Genomic information is increasingly used to inform medical treatments and manage future disease risks. However, any personal and societal gains must be carefully balanced against the risk to individuals contributing their genomic data. Expanding our understanding of actionable genomic insights requires researchers to access large global datasets to capture the complexity of genomic contribution to diseases. Similarly, clinicians need efficient access to a patient's genome as well as population-representative historical records for evidence-based decisions. Both researchers and clinicians hence rely on participants to consent to the use of their genomic data, which in turn requires trust in the professional and ethical handling of this information. Here, we review existing and emerging solutions for secure and effective genomic information management, including storage, encryption, consent, and authorization that are needed to build participant trust. We discuss recent innovations in cloud computing, quantum-computing-proof encryption, and self-sovereign identity. These innovations can augment key developments from within the genomics community, notably GA4GH Passports and the Crypt4GH file container standard. We also explore how decentralized storage as well as the digital consenting process can offer culturally acceptable processes to encourage data contributions from ethnic minorities. We conclude that the individual and their right for self-determination needs to be put at the center of any genomics framework, because only on an individual level can the received benefits be accurately balanced against the risk of exposing private information.

multidisciplinary sciences
Histamine metabolism in the pregnant mouse

E. Rosengren

DOI: https://doi.org/10.1113/jphysiol.1963.sp007275

1963-12-01

Journal of Physiology

Abstract:Profound changes in histamine metabolism during pregnancy have been observed in various mammalian species. Particularly conspicuous is the high embryonic histamine-forming capacity (HFC) in the rat (Kahlson, Rosengren & Westling, 1958; Kahlson, Rosengren, Westling & White, 1958) and in man (Kahlson, Rosengren & White, 1959; for full references to human embryo see Lindell & Westling, 1963), which has been examined in considerable detail. The rat, during the last week of pregnancy, excretes excessive amounts of free histamine with a return to the prepregnant level at term or on surgical removal of the foetuses. On closer examination of various rat embryonic tissues the liver was found to produce histamine at an extraordinarily high rate, the histidine decarboxylase level being about a thousand times higher than in the maternal liver (Kahlson, Rosengren & White, 1960). Embryonic tissues other than the liver, such as the lung and the stomach, also proved to have a high histamine-forming capacity; every embryonic rat tissue examined produced histamine. Obviously, then, in pregnancy the elevated HFC resides in the rat embryo. The rat embryonic histidine decarboxylase has been shown to be specific for histidine in so far as this enzyme is strongly inhibited by oc-methylhistidine and only weakly by oc-methyl-DOPA (Kahlson, Rosengren & Thunberg, unpublished), and differs from the non-specific decarboxylase which also decarboxylates various aromatic amino acids. This L-amino acid decarboxylase is activated by benzene and inhibited by ac-methylDOPA (Weissbach, Lovenberg & Udenfriend, 1961). Histamine formation during pregnancy is being studied in several species in this laboratory. In the guinea-pig and in the cat the embryonic tissues produce histamine by decarboxylation of histidine, but this has not yet been studied as comprehensively as in the rat. In the pregnant mouse, by contrast, although the changes in histamine metabolism are more diverse than in the rat, the pattern appears sufficiently clear to justify a report of what has been found so far.
Digital sequence information–legal questions for patent, copyright, trade secret protection and sharing of genomic sequencing data

C Seitz

DOI: https://doi.org/10.1088/1755-1315/482/1/012002

2020-03-01

IOP Conference Series: Earth and Environmental Science

Abstract:Abstract Advances in sciences–both in molecular biology and information technology–have enabled new understandings of genetic resources and biological processes which lead to an ongoing fundamental paradigm shift. The phenomenon of big data resulting from genomic sequencing has emerged as a consequence of next generation sequencing technologies that generate large data sets in biotechnological research. Technical progress in such big data generation and management has opened previously unprecedented possibilities for research, the development of new products and leads to a vast amount of data being generated at an unprecedented speed, ranging from the extraction of information to data analysis and interpretation. While there will always remain a reliance on genetic materials, one may observe a trend that research and development activities using genetic materials are increasingly supplemented or substituted by computerized research activities based on digital sequence information (DSI). These developments lead to a revolutionary transformation in the use of genetic resources (GR), which is currently undergoing radical changes and may be considered as a “fourth industrial revolution”. It results not only in exponential growth of generated genetic data, which may lead to innovation and new products and services, but also poses a range of new regulatory and legal questions due to its specific characteristics. The rise of big data raises specific legal challenges in terms of data ownership and intellectual property, data stewardship and governance, as well as technology transfer and licensing. One example is the question on how to regulate access and benefit-sharing for plant genetic resources and regulatory approvals for gene-edited plants as a result of new genomic technologies, which illustrates the use of DSI as an essential tool for research and development along with the requirements to exchange such information. Existing exchange mechanisms include, for instance, open-access databases and DSI platforms. Their data access and exchange policies would presumably be intended to maintain consistency with the objectives, policies and regulations of the Access and Benefit-Sharing system (ABS system). A large number of these questions are currently subject to discussions on an international, regional, as well as on a national level. This paper shall shed light on some of these questions to reflect the current and ongoing discussion on the issue and focus on the protection of DSI and address the question of the application of ABS systems to DSI.
Temperature regulation during exercise in water and air.

B. Nielsen,C. Davies

DOI: https://doi.org/10.1111/J.1748-1716.1976.TB10342.X

1976-12-01

Acta Physiologica Scandinavica

Abstract:Four healthy subjects were studied during exercise in water, using a swimming flume, and in air, on a stationary bicycle ergometer at mean skin temperatures of 30 and 33 degrees C, respectively. Measurements included rectal (Tre), esophageal (Tes), and mean skin (Ts) temperatures, metabolic energy liberation (M) and total heat production (H), maximal aerobic power output (Vo2 max), cardiac frequency and calculated peripheral tissue heat conductance (K). The results showed that for a given M and Ts, Tes and Tre were about 0.4 degree C lower and the K values were consistently higher in swimming than in bicycling. The intersubject variability in Tes and Tre was reduced by considering relative (expressed as %VO2max) rather than absolute work load, but the differences in the body temperatures between the two types of exercise remained. It was concluded that during exercise in water where the capacity for heat dissipation is increased, the body core temperature (Tc) is maintained at a lower level due to the higher forced convective and conductive heat transfer from the skin in water. This reduces the heat storage at the beginning of exercise compared with conditions in air. The lower Tc-Ts gradient for a given H in swimming, which results in higher K values implies a greater skin circulation than during cycling in air.

Degos's Syndrome.

Enabling responsible public genomics

Public perceptions of international genetic information sharing for biomedical research in China: a case study of the social media debate on the article "A Pangenome Reference of 36 Chinese Populations" published in Nature

Regulatory Barriers to US-China Collaboration for Generative AI Development in Genomic Research

Ethical challenges related to biomedical data sharing in China: A systematic literature review

South Korea: in the midst of a privacy reform centered on data sharing

Teaming Up? China, India and Brazil and the Issue of Benefit-Sharing from Genetic Resource Use

Ethical, Legal, and Social Implications of Genomics in China: A Scoping Review and Implications for Precision Public Health.

Collaborative analysis of genomic data: vision and challenges

Resistance training during unweighting maintains muscle size and function in human calf.

The ethics weathervane

Privacy in the Genomic Era

Effect of Side Feed Pressurization on the Performance of Shimmed Foil Gas Bearings-Part II : Model , Predictions and Comparisons to Rotordynamic Measurements

A nation's genes for a cure to cancer: evolving ethical, social and legal issues regarding population genetic databases

Bridging the European Data Sharing Divide in Genomic Science

A call to action to scale up research and clinical genomic data sharing

Toward unrestricted use of public genomic data

Future-proofing genomic data and consent management: a comprehensive review of technology innovations

Histamine metabolism in the pregnant mouse

Digital sequence information–legal questions for patent, copyright, trade secret protection and sharing of genomic sequencing data

Temperature regulation during exercise in water and air.